Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aldeyra Therapeutics

3.79
-0.0800-2.07%
Post-market: 3.850.0567+1.50%19:55 EDT
Volume:2.54M
Turnover:9.70M
Market Cap:227.00M
PE:-3.92
High:4.00
Open:3.97
Low:3.74
Close:3.87
Loading ...
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Major Issues Report

Form 8-K - Current report
Jun 13, 2024

Major Issues Report

Form 8-K - Current report
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 25, 2024

Major Issues Report

Form 8-K - Current report
Apr 23, 2024

Correspondence

Form CORRESP - Correspondence
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Mar 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 07, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 07, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024

Major Issues Report

Form 8-K - Current report
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Dec 22, 2023

Major Issues Report

Form 8-K - Current report